Menu

CME Corner

Active Programs

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and non-familial hypercholesterolemia, but many patients remain unable to achieve optimal reductions in their LDL-C levels. This interactive case-based activity will examine the consequences of elevated LDL-C and explore strategies for achieving target LDL-C goals. ...

  • Online Presentation Online Presentation
  • ACCME

Strategies for Improving Outcomes in Patients with Parkinson's Disease

Parkinson’s disease (PD) affects roughly one million Americans and more than 10 million people worldwide. It is a progressive neurologic disorder characterized by motor and nonmotor symptoms. Key motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. Nonmotor symptoms include psychosis, depression, anxiety, impulse control disorders, cognitive impairment, and slee ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Clinical Insights in Pediatrics: Type 2 Diabetes in Children and Adolescents with Obesity

The incidence and prevalence of obesity in children and adolescents has increased in recent years, and with it the incidence and prevalence of type 2 diabetes mellitus (T2DM). Compared with adults, T2DM in pediatric patients frequently progresses more rapidly, with high rates of early development of comorbidities and often with a less favorable response to treatment. The American Diabetes Associat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Update on Psoriatic Arthritis: Best Practices in Rheumatology

Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisci ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Update on Psoriasis and Psoriatic Arthritis: Best Practices in Dermatology

Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisci ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Optimizing Immunization in IBD: A Quality Improvement Curriculum, Part 1

This activity simulates a quality improvement initiative to illuminate best practices in the immunization of patients with IBD. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

The Pharmacist's Role in Advanced or Metastatic Breast Cancer

Cyclin-dependent kinase (CDK) 4/6 inhibition significantly prolongs progression-free survival (PFS) in patients with metastatic breast cancer (mBRCA) whose disease progresses on endocrine therapies. This activity will examine emerging evidence and best practices supporting the use of CDK4/6 inhibitors. This activity was originally presented as a webcast series on the following 4 dates: February ...

  • Online Presentation Online Presentation
  • ACPE

Evolving Standards of Care in Metastatic Prostate Cancer

For patients with metastatic prostate cancer (mPRCA), the number of metastases has prognostic and therapeutic implications. Clinicians who treat patients with mPRCA need to recognize patients with oligometastatic prostate cancer and be aware that management of patients with fewer than 5 metastases is different from that of patients with polymetastatic disease. Recommendations for the initial manag ...

  • Online Presentation Online Presentation
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation Online Presentation
  • ACCME

Psoriasis and Psoriatic Arthritis: Strategies for Targeted Care and Multidisciplinary Management

Psoriatic disease can have a substantial negative impact on patients’ quality of life. The treatments for psoriasis and PsA can overlap, although additional measures should be taken in patients with PsA to slow progression of joint damage, manage pain, and promote mobility for optimal quality of life. This activity will provide learners with strategies for effective multidisciplinary management of ...

  • Online Presentation Online Presentation
  • ACCME

Contemporary Management of Type 2 Diabetes

The management of type 2 diabetes (T2D) remains a clinical challenge as patients continue to struggle with achieving therapeutic goals. While there are many treatment options for T2D, there is relatively limited guidance on selection of second- and third-line treatments. This activity will review the most recent T2D treatment guidelines (including strategies for patient communication), and address ...

  • Online Presentation Online Presentation
  • ACCME

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will e ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Diagnosis of Pediatric Allergic Asthma

In the United States, 8.6% of children (approximately 6.3 million) have asthma, and ~80% of these children have allergic asthma. This activity will review the epidemiology of pediatric allergic asthma and outline strategies for diagnosis, assessment of severity, and initial therapy. ...

  • Online Presentation Online Presentation
  • ACCME

Individualized Management of Pediatric Allergic Asthma

An evolving understanding of pediatric allergic asthma’s complex immunopathology is contributing to new treatment paradigms. This activity will examine the impact of asthma phenotypes and endotypes on treatment selection. ...

  • Online Presentation Online Presentation
  • ACCME

The Role of the Pharmacist in T2D: The Evolution of Insulin Therapy

This activity uses interactive case scenarios to examine the role of the pharmacist in the management of T2D. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACPE

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Team-Based Care for Patients with Type 2 Diabetes (Activity 3 of 3)

This activity employs a multidisciplinary panel to examine the various clinical roles in the management of T2DM. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Case Challenges in the Use of Insulin in T2DM (Activity 2 of 3)

This activity uses interactive case scenarios to examine challenges in the management of T2DM. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Updates in Psoriasis and Psoriatic Arthritis Management: Best Practices for Effective Care (Program ID: 17022536)

This program will examine the pathogenesis of psoriasis and PsA, evidence-based guidelines for diagnosis and treatment, and the expanding therapeutic options available for each condition. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Improving Outcomes in Patients with Heart Failure: Closing the Gaps

In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates of cardiovascular death or HF-r ...

  • Online Presentation Online Presentation
  • ACCME

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Management of T2DM: The Role of Insulin (Activity 1 of 3)

This activity examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Improving Outcomes in Advanced Gastric Cancer: The Latest Updates in Treatment Strategies and Clinical Research

An estimated 26,370 Americans will be diagnosed with gastric cancer in 2016. Most patients with gastric cancer present with advanced or metastatic disease, for which the prognosis is poor. The 5-year survival rate of patients with all stages of gastric cancer in the United States is approximately 29% and drops into the single digits for patients with stage III or IV disease. However, recent advanc ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Early Collaboration in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often goes undiagnosed and untreated. This activity will examine strategies for early recognition and referral, as well as specialty collaboration in the treatment of PsA. ...

  • i-Newsletter i-Newsletter
  • ACCME

The Importance of Continued Co-management in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often requires collaborative care between dermatologists, rheumatologists, and primary care clinicians. This activity will examine specialty collaboration and guideline recommended treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME

Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Diseases

Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions. ...

  • Video Roundtable Video Roundtable
  • ACCME

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Multidisciplinary Care of Patients with Relapsed/Refractory Multiple Myeloma

The treatment landscape for multiple myeloma (MM) is rapidly evolving. This activity will examine tailored treatment approaches for patients with relapsed/refractory multiple myeloma. ...

  • Online Presentation Online Presentation
  • ACCME

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Secondary Prevention of ASCVD: Novel Therapies to Improve Outcomes in Patients with Hypercholesterolemia (AANP Program ID 17012508)

This activity will examine the current discussions surrounding statin use and the potential application of PCSK9 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Best Practices in the Use of Incretin-based Therapies in the Management of Type 2 Diabetes (AANP Program ID 16032139)

This activity will address glycemic variability and cardiovascular considerations in patients with T2DM and examine therapeutic management, with a particular focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Clinical Insights in Pediatrics (an i-Newsletter series)

Clinical Insights in Pediatrics (an i-Newsletter series) ...

  • Series
  • ACCME
  • NAPNAP

Expired Programs

Acute Heart Failure: Current Best Practices, Ongoing Challenges, and Future Directions

Each year, more than 1 million individuals are hospitalized for heart failure (HF). Within the spectrum of HF, acute heart failure (AHF) represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to reco ...

  • Online Presentation Online Presentation
  • ACCME

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment (Program ID 16052200)

Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of th ...

  • Online Presentation Online Presentation
  • AANP

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Primary Care Perspectives: Recognizing and Managing Opioid-Induced Constipation

Constipation is a common adverse effect resulting from opioid medications: an estimated 40% of patients receiving opioids to manage noncancer pain experience opioid-induced constipation (OIC). Unlike other adverse effects of opioids, such as nausea, the severity of OIC rarely diminishes over time and is often dose limiting. As a result, OIC can have a significant negative impact on activities of d ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy (Program ID: 15111981)

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. Individuals with AF have a 4 to 5 times greater risk for ischemic stroke. The National Stroke Association emphasizes the importanc ...

  • Online Presentation Online Presentation
  • AANP

Stroke Prevention in Atrial Fibrillation: Tailoring Anticoagulation Therapy for Optimal Outcomes

A CPE-certified interactive newsletter with highlights from the American Society of Consultant Pharmacists workshop. Although most AF-related strokes can be prevented with anticoagulation medication, many older adults are not receiving optimal evidence-based therapy for stroke prevention. This activity will address persistent barriers to the appropriate use of anticoagulation therapy for the p ...

  • i-Newsletter i-Newsletter
  • ACPE

The Evolving Migraine Paradigm: Improving Diagnostic Accuracy

Migraine is underdiagnosed, frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to diagnose migraine, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Tailoring Treatment

Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 1: Diagnosis and Initial Treatment Options

Inflammatory bowel disease (IBD) can be challenging to diagnose because of its heterogeneous and somewhat ambiguous clinical presentation. Despite the challenges, primary care clinicians are on the front line for assessment and initial diagnosis of these patients. Once diagnosed, even if placed under the care of a gastroenterologist, these patients will require life-long care. This activity, the f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 2: Escalating Therapy, Addressing Treatment Risks, and Co-Managing With Specialists

Patients with inflammatory bowel disease (IBD) who present with moderate to severe disease, or who relapse after treatment for mild disease will often require treatment with additional forms of therapy. Primary care clinicians are on the front line for monitoring their patients for treatment response and adverse events. This activity, the second in a 3-part series, addresses escalation of therapy ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 3: Improving Adherence, Monitoring, and Communication

Inflammatory bowel disease is commonly associated with a wide range of extraintestinal manifestations that may appear in a variety of locations throughout the body. This activity, the third in a 3-part series, will review these manifestations and the primary care clinician’s role in identifying/investigating them. It will also examine patient non-adherence to medication and offer suggestions for f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS